Complication Rates of PCI in Patients With Renal Impairment

doi:N/A

eISSN: 1994-4624 / ISSN: 1813-176x

International Journal of Molecular Medicine and Advance Sciences

2021, Volume 17, Issue 1 : 1-4

Research Article

Complication Rates of PCI in Patients With Renal Impairment

Aakash Verma

Laila Hussain

Rahman Siddiqui

Department of Cardiology, Northeast Institute of Medical Sciences, Guwahati, India

Department of Nephrology, Kolkata Medical Research Centre, Kolkata, India

Department of Biomedical Research, International Healthcare University, Malaysia

Received

Feb. 18, 2021

Revised

April 29, 2021

Accepted

May 11, 2021

Published

June 21, 2021

Abstract

Percutaneous Coronary Intervention (PCI) is a widely used revascularization technique for patients with coronary artery disease. However, individuals with renal impairment exhibit significantly higher rates of procedural and post-procedural complications. This study evaluates complication rates of PCI across varying stages of renal dysfunction in patients undergoing emergency and elective angioplasty. A retrospective cohort of 842 patients was studied from 2020–2024, categorized based on estimated glomerular filtration rate (eGFR). Findings revealed that patients with severe renal impairment had higher incidences of contrast-induced nephropathy (CIN), in-stent thrombosis, periprocedural myocardial infarction, and mortality. The research recommends modified procedural dosing, use of iso-osmolar contrast agents, and post-procedure hydration protocols to improve clinical outcomes.

Keywords

Percutaneous Coronary Intervention

Renal impairment

Contrast-induced nephropathy

Cardiovascular complications

EGFR

Stent thrombosis.

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients

Arif Mohammad,

Sophia Menon,

Carlos E. Martinez

41-45

Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies

Jennifer L. Roberts,

Ahmed M. Hassan,

Priyanka S. Nair

1-4

Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare